🚀 AI-picked stocks soar in May. PRFT is +55%—in just 16 days! Don’t miss June’s top picks.Unlock full list

Omicron sub-variant BA.2 harder to identify, found in 5 African nations -WHO

Published 02/03/2022, 06:53 AM
Updated 02/03/2022, 06:57 AM
© Reuters. Test tube labelled "COVID-19 Omicron variant test positive" is seen in this illustration picture taken January 15, 2022. REUTERS/Dado Ruvic/Illustration
TGT
-

JOHANNESBURG (Reuters) -The BA.2 sub-variant of Omicron has been found in five African countries, a World Health Organization scientist said on Thursday, adding she was concerned about the development because samples of BA.2 may not be spotted as a form of Omicron.

The BA.2 sub-variant has begun to replace Omicron's more common "original" BA.1 variant in countries such as Denmark. Data from there suggests no difference in disease severity, according to another WHO official.

"BA.2 ... has been reported in five countries, that is Botswana, Kenya, Malawi, Senegal as well as South Africa," Dr Nicksy Gumede-Moeletsi told an online media briefing.

"We are very concerned," she said, adding that BA.2 was proving hard to identify because it was not always picked up by the S-Gene Target (NYSE:TGT) Failure criterion, which is used to distinguish the original Omicron from other variants.

Gumede-Moeletsi said the WHO was working very closely with laboratories, asking them to forward samples that had come back without being flagged as Omicron for further analysis, in order to gain a more precise picture of the spread of BA.2.

The BA.1 version of Omicron has been somewhat easier to track than prior variants. That is because BA.1 is missing one of three target genes used in a common PCR test. Cases showing this pattern were assumed by default to be caused by BA.1.

BA.2, sometimes known as a "stealth" sub-variant, does not have the same missing target gene as the original Omicron variant.

© Reuters. Test tube labelled

Instead, scientists are monitoring it the same way they have prior variants, including Delta, by tracking the number of virus genomes submitted to public databases such as GISAID.

As with other variants, an infection with BA.2 can be detected by coronavirus home tests kits, though they cannot indicate which variant is responsible, experts said.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.